keyword
https://read.qxmd.com/read/38691847/activation-of-hepatocyte-growth-factor-met-signaling-as-a-mechanism-of-acquired-resistance-to-a-novel-yap1-tead-small-molecule-inhibitor
#1
JOURNAL ARTICLE
Casey J Moure, Brandon Vara, Mangeng M Cheng, Christopher Sondey, Eric Muise, Eunsil Park, Julia Eulalia Vela Ramirez, Dan Su, Shanti D'Souza, Qingyun Yan, Charles S Yeung, Minjia Zhang, My Sam Mansueto, Doug Linn, Mark Buchanan, Robert Foti, Erin DiMauro, Brian Long, Vladimir Simov, Evan R Barry
Many tumor types harbor alterations in the Hippo pathway, including mesothelioma, where a high percentage of cases are considered YAP1/TEAD dependent. Identification of autopalmitoylation sites in the hydrophobic palmitate pocket of TEADs, which may be necessary for YAP1 protein interactions, has enabled modern drug discovery platforms to generate compounds that allosterically inhibit YAP1/TEAD complex formation and transcriptional activity. We report the discovery and characterization of a novel YAP1/TEAD inhibitor MRK-A from an aryl ether chemical series demonstrating potent and specific inhibition of YAP1/TEAD activity...
May 1, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38691846/exploiting-metabolic-defects-in-glioma-with-nanoparticle-encapsulated-nampt-inhibitors
#2
JOURNAL ARTICLE
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee-Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
The treatment of primary central nervous system (CNS) tumors is challenging due to the blood-brain barrier and complex mutational profiles, which is associated with low survival rates. However, recent studies have identified common mutations in gliomas (IDH-WT and mutant, WHO grades II-IV; with grade IV tumors referred to as glioblastomas; GBMs). These mutations drive epigenetic changes, leading to promoter methylation at the NAPRT gene locus, which encodes an enzyme involved in generating NAD+. Importantly, NAPRT-silencing introduces a therapeutic vulnerability to inhibitors targeting another NAD+ biogenesis enzyme, NAMPT, rationalizing a treatment for these malignancies...
May 1, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38691840/adalimumab-for-the-treatment-of-non-infectious-uveitis-a-real-life-experience
#3
JOURNAL ARTICLE
Fátima Raad, Paula Luque, Sofía García Ledo, Alicia Alda Lozano, Víctor Llorens, Antonio Espejo, Henar Heras, Lucía Santana, Luis Trapiella, Patricia Fanlo, Alfredo Adán, Gerard Espinosa, Nuria Navarrete
OBJECTIVE: To describe the efficacy and safety of adalimumab for the treatment of non-infectious uveitis (NIU) in four Uveitis Units from tertiary Spanish hospitals. METHODS: Multicenter and retrospective clinical cohort study including all patients with NIU treated with adalimumab from January 2012 to October 2022 in four uveitis units was performed. Efficacy was measured with the number of relapses, ocular inflammation and reduction in immunosuppression and corticosteroid dosage before and after adalimumab use...
May 1, 2024: Ocular Immunology and Inflammation
https://read.qxmd.com/read/38691784/assessment-of-antimicrobial-drugs-employed-at-government-operated-hospitals-in-central-and-northern-provinces-of-iraq
#4
JOURNAL ARTICLE
Mahmood Jawad, Shathel Khalaf Noman, Mohammed Rasool
OBJECTIVE: Aim: To document the clinical patterns of antibiotic prescriptions in government hospitals, where the majority of physicians possess a degree-based training. PATIENTS AND METHODS: Materials and Methods: A Retrospective cross section study carried out between 1/7/2022 and April 2023 that enrolling 300 patients from governmental hospitals from different provinces of Central and northern Iraq. The research form contained 15 fields divided into three sections...
2024: Wiadomości Lekarskie: Organ Polskiego Towarzystwa Lekarskiego
https://read.qxmd.com/read/38691482/therapeutic-drug-monitoring-of-levetiracetam-in-different-trimesters-of-pregnant-women-with-epilepsy-in-a-tertiary-care-center-a-prospective-study
#5
JOURNAL ARTICLE
J Kumaravel, Phulen Sarma, Vanita Suri, Parampreet Singh, Ajay Prakash, Bikash Medhi
BACKGROUND: Levetiracetam is the most commonly used antiepileptic drug in pregnant women due to its low teratogenic risk profile, favorable pharmacokinetic characteristics, and safety profile. Serum levels of levetiracetam vary in epilepsy during pregnancy. Therefore, the aim of the study was to evaluate the serum levels of levetiracetam during different trimesters of pregnancy by using therapeutic drug monitoring (TDM). MATERIALS AND METHODS: This was a single-center, prospective study...
March 1, 2024: Neurology India
https://read.qxmd.com/read/38691440/antibiotic-dose-and-nutrient-availability-differentially-drive-the-evolution-of-antibiotic-resistance-and-persistence
#6
JOURNAL ARTICLE
Etthel M Windels, Lloyd Cool, Eline Persy, Janne Swinnen, Paul Matthay, Bram Van den Bergh, Tom Wenseleers, Jan Michiels
Effective treatment of bacterial infections proves increasingly challenging due to the emergence of bacterial variants that endure antibiotic exposure. Antibiotic resistance and persistence have been identified as two major bacterial survival mechanisms, and several studies have shown a rapid and strong selection of resistance or persistence mutants under repeated drug treatment. Yet, little is known about the impact of the environmental conditions on resistance and persistence evolution, and the potential interplay between both phenotypes...
May 1, 2024: ISME Journal
https://read.qxmd.com/read/38691205/translational-two-pore-pbpk-model-to-characterize-whole-body-disposition-of-different-size-endogenous-and-exogenous-proteins
#7
JOURNAL ARTICLE
Shufang Liu, Yingyi Li, Zhe Li, Shengjia Wu, John M Harrold, Dhaval K Shah
Two-pore physiologically based pharmacokinetic (PBPK) modeling has demonstrated its potential in describing the pharmacokinetics (PK) of different-size proteins. However, all existing two-pore models lack either diverse proteins for validation or interspecies extrapolation. To fill the gap, here we have developed and optimized a translational two-pore PBPK model that can characterize plasma and tissue disposition of different-size proteins in mice, rats, monkeys, and humans. Datasets used for model development include more than 15 types of proteins: IgG (150 kDa), F(ab)2 (100 kDa), minibody (80 kDa), Fc-containing proteins (205, 200, 110, 105, 92, 84, 81, 65, or 60 kDa), albumin conjugate (85...
May 1, 2024: Journal of Pharmacokinetics and Pharmacodynamics
https://read.qxmd.com/read/38691150/safety-pharmacokinetics-and-food-effect-of-pivmecillinam-after-single-and-multiple-dose-in-healthy-chinese-subjects-a-phase-i-study
#8
JOURNAL ARTICLE
Lu-Lu Zhang, Yi Liu, Qiong-Ye Huang, Hong-Wen Zhang, Li-Jun Xie, Juan Chen, Li Ding, Chen Zhou, Lu-Ning Sun, Yong-Qing Wang
Urinary tract infection (UTI) is one of the most prevalent bacterial infectious diseases worldwide. However, the resistance of urinary pathogens to other UTI antibiotics such as trimethoprim and trimethoprim/sulphamethoxazole increased. Pivmecillinam is a prodrug of mecillinam, which is effective for the treatment of urinary tract infections. The purpose of this study was to assess the safety, and pharmacokinetics of pivmecillinam and mecillinam after single- and multiple-dose oral administration of pivmecillinam tablets in healthy Chinese subjects...
May 1, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38691139/pharmacokinetics-of-nirmatrelvir-ritonavir-and-the-drug-drug-interaction-with-calcineurin-inhibitor-in-renal-transplant-recipients
#9
JOURNAL ARTICLE
Xueyin Xu, Huanxi Zhang, Longshan Liu, Qian Fu, Chenglin Wu, Xiaobin Lin, Kejing Tang, Changxi Wang, Pan Chen
OBJECTIVES: To describe the pharmacokinetic (PK) characteristics of nirmatrelvir/ritonavir in renal transplant recipients and explore the potential factors that related to the PK variance of nirmatrelvir/ritonavir and its interaction with calcineurin inhibitor (CNI). METHODS: Renal transplant recipients treated with CNI and nirmatrelvir/ritonavir were prospectively enrolled. Steady-state plasma concentrations of nirmatrelvir/ritonavir were determined by high-performance liquid chromatography-tandem mass spectrometry, and the PK parameters were calculated using non-compartmental analysis...
May 1, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/38691085/the-risk-of-kidney-injury-in-patients-with-sickle-cell-disease-treated-with-ketorolac-for-acute-pain
#10
JOURNAL ARTICLE
Emily M Harris, Morohuntodun O Oni, Carolina Donado, Matthew M Heeney, Jean Solodiuk, Christine Greco, Natasha M Archer
Ketorolac, a nonsteroidal anti-inflammatory drug, is used in combination with opioids to manage vaso-occlusive episodes (VOEs). The relationship between ketorolac use and kidney injury in pediatric patients with sickle cell disease (SCD) remains incompletely understood. We hypothesize that ketorolac is associated with acute kidney injury (AKI) in patients with SCD presenting with pain. All nonsurgical hospitalizations for VOEs treated with ketorolac between January 2014 and December 2022 were included. We used optimal matching methodology to identify control admissions (2:1 ratio) and used nonparametric tests to compare ketorolac administration between cases and controls...
May 1, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38691057/metronomic-chemotherapy-for-pediatric-refractory-solid-tumors-a-retrospective-single-center-study
#11
JOURNAL ARTICLE
Yukari Sakurai, Fuminori Iwasaki, Ayana Hirose, Naoya Matsumoto, Naoyuki Miyagawa, Dai Keino, Tomoko Yokosuka, Satoshi Hamanoue, Masakatsu Yanagimachi, Masae Shiomi, Shoko Goto, Mio Tanaka, Yukichi Tanaka, Kumiko Nozawa, Hiroaki Goto
Metronomic chemotherapy (MC) is based on chronic administration of chemotherapeutic agents at minimally toxic doses without prolonged drug-free breaks, that inhibits tumor angiogenesis and induces tumor dormancy. This study aimed to determine the efficacy of MC for pediatric refractory solid tumors. We retrospectively analyzed the data of pediatric patients with relapsed/refractory solid tumors who received treatment, including low-dose continuous administration of anticancer drugs, at our institute. Of the 18 patients, the disease statuses at the initiation of MC were complete remission (n=2), partial remission/stable disease (n=5), and progressive disease (n=11)...
April 29, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38690782/development-of-a-physiologically-based-pharmacokinetic-model-of-fostemsavir-and-its-pivotal-application-to-support-dosing-in-pregnancy
#12
JOURNAL ARTICLE
Farzaneh Salem, Dung Nguyen, Mark Bush, Katy P Moore, Jennypher Mudunuru, Konstantinos Stamatopoulos, Nilay Thakkar, Kunal S Taskar
It is critical to understand the impact of significant physiological changes during pregnancy on the extent of maternal and fetal drug exposure. Fostemsavir (FTR) is a prodrug of temsavir (TMR) and is approved in combination with other antiretrovirals for multi-drug-resistant human immunodeficiency virus (HIV) infections. This physiologically based pharmacokinetic model (PBPK) study was used to estimate TMR PK in pregnant populations during each trimester of pregnancy to inform FTR dosing. A PBPK model was developed and validated for TMR using PK data collected following intravenous TMR and oral FTR dosing (immediate-release and extended-release tablets) in healthy volunteers...
May 1, 2024: CPT: Pharmacometrics & Systems Pharmacology
https://read.qxmd.com/read/38690558/repeated-occurrence-of-severe-hypotension-associated-with-azithromycin-infusion-in-a-patient-with-fulminant-myocarditis-a-case-report
#13
Max Lenz, Konstantin A Krychtiuk, Robert Zilberszac, Walter S Speidl, Gottfried Heinz
BACKGROUND: Intravenous administration of azithromycin has been linked to severe hypotension in some case reports in the past. We report a further case of profound shock requiring excessive use of vasopressors and extracorporeal membrane oxygenation (ECMO). CASE SUMMARY: An 18-year-old Caucasian male was admitted due to fulminant myocarditis and signs of cardiogenic shock. He had to be put on venoarterial ECMO only hours after admission. Due to the occurrence of disseminated intravascular coagulation and heparin-induced thrombocytopenia, haemodynamic support was discontinued on Day 8...
April 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38690495/targeted-drug-delivery-for-the-treatment-of-abdominal-pain-in-chronic-pancreatitis-a-retrospective-case-series
#14
JOURNAL ARTICLE
Guy P Cooper, Victor Progar, Kelly Grott, Feenalie Patel, Jackie Mon, Benjamin Bick, Timothy D Kelly, Raheleh Rahimi Darabad
UNLABELLED: Abdominal pain secondary to chronic pancreatitis (CP) is difficult to manage and often requires chronic oral opioid therapy (OOT). Targeted drug delivery (TDD) allows for a diminished dose of opioid intake and improved pain levels. TDD has been used in different pain syndromes with only limited reports in CP. OBJECTIVE: The objective of this article is to perform a retrospective review of CP patients treated with TDD versus OOT to compare chronic pain control and consumed morphine-equivalent doses...
March 2024: Curēus
https://read.qxmd.com/read/38690111/synthesis-and-characterization-of-new-composite-from-modified-silica-coated-mnfe-2-o-4-nanoparticles-for-removal-of-tetracycline-from-aqueous-solution
#15
JOURNAL ARTICLE
Alireza Banaei, Afshin Saadat, Negar Gharibzadeh, Parinaz Pargol Ghasemi
In this study, a new composite from silica coated MnFe2 O4 nanoparticles, diethylenetriamine, 3-chloropropyl trimethoxysilane and Mg-Al Layered Double Hydroxide (Mg-Al LDH/DETA/CPTMS/SCNPs) composite was synthesized. The Mg-Al LDH/DETA/CPTMS/SCNPs composite was examined by Fourier transform infrared spectrometer (FT-IR), Scanning Electron Microscopy (SEM), Energy Dispersive X-ray (EDS), X-ray diffraction (XRD), Thermogravimetric Analysis (TGA) and Vibrating Sample Magnetometry (VSM). The synthesized composite exhibited magnetic property with a saturation magnetization of 0...
April 25, 2024: RSC Advances
https://read.qxmd.com/read/38690012/anti-inflammatory-activity-of-d-pinitol-possibly-through-inhibiting-cox-2-enzyme-in-vivo-and-in-silico-studies
#16
JOURNAL ARTICLE
Mst Farjanamul Haque, Heba A S El-Nashar, Md Showkoth Akbor, Mohammed Alfaifi, Mehedi Hasan Bappi, Afsana Kabir Chowdhury, Muhammad Kamal Hossain, Mohamed El-Shazly, Tala Albayouk, Na'il Saleh, Muhammad Torequl Islam
Introduction: D-pinitol, a naturally occurring inositol, has diverse biological activities like antioxidant, antimicrobial and anticancer activities. This study aimed to evaluate anti-inflammatory effect of d-pinitol in a chick model. Additionally, in silico studies were performed to evaluate the molecular interactions with cyclooxygenase-2 (COX-2). Methods: The tested groups received d-pinitol (12.5, 25, and 50 mg/kg) and the standard drugs celecoxib and ketoprofen (42 mg/kg) via oral gavage prior to formalin injection...
2024: Frontiers in Chemistry
https://read.qxmd.com/read/38689791/pattern-of-traumatic-injuries-in-patients-with-tramadol-poisoning-a-cross-sectional-study-in-a-tertiary-care-hospital
#17
JOURNAL ARTICLE
Seyed Mostafa Mirakbari, Amir Mohammad Kazemifar, Abbas Allami, Ameneh Barikani
OBJECTIVE: This study aimed to investigate the incidence and pattern of tramadol-induced seizures and injuries in patients admitted to the hospital. METHODS: The cross-sectional study included 300 patients with alleged tramadol intoxication. Demographic information, tramadol dosage and duration of abuse, co-existing illicit drug abuse, hospital stay length, and occurrence of seizures and trauma (type and site of injuries) were collected. Different statistical tests, including the Mann-Whitney U-test, Pearson's Chi-square test, and Student's t-test, were conducted to compare the patients with and without seizures, trauma, and co-ingestion of illicit drugs...
2024: Bulletin of Emergency and Trauma
https://read.qxmd.com/read/38689550/editorial-first-regulatory-approval-for-adoptive-cell-therapy-with-autologous-tumor-infiltrating-lymphocytes-tils-lifileucel-amtagvi
#18
EDITORIAL
Dinah V Parums
On February 16, 2024, the US Food and Drug Agency (FDA) granted accelerated approval to lifileucel (Amtagvi), an adoptive immune cell therapy with autologous ex vivo-expanded tumor-infiltrating lymphocytes (TILs) for adult patients with advanced or unresectable melanoma progressing after treatment with immune checkpoint inhibitors and, if BRAF V600 mutation-positive, BRAF/MEK inhibitors. The clinical studies supporting this regulatory approval have highlighted the complexity of the treatment manufacturing process and the requirements for patient selection, a pretreatment lymphodepletion regimen, followed by a single infusion of lifileucel (Amtagvi), and up to six treatments with high-dose IL-2, with the potential for adverse events at each stage of treatment...
May 1, 2024: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
https://read.qxmd.com/read/38689399/research-priorities-in-tranexamic-acid-after-trauma-secondary-analysis-of-the-national-trauma-research-action-plan
#19
JOURNAL ARTICLE
Alexandra Brito, Jonathan Meizoso, Todd Costantini
INTRODUCTION: Tranexamic Acid (TXA) is an antifibrinolytic drug that is used in traumatic hemorrhage and TBI. Although TXA is considered relatively safe, inexpensive and is widely available, data regarding its mechanisms, optimal dosing, and timing, as well as relative risks and benefits for different patient populations, are inconsistent. In this study we aim to identify and summarize consensus research questions related to TXA across all NTRAP Delphi expert panels to identify priorities for future research on TXA in trauma...
May 1, 2024: Journal of Trauma and Acute Care Surgery
https://read.qxmd.com/read/38689257/access-to-quality-assured-artemisinin-based-combination-therapy-and-associated-factors-among-clients-of-selected-private-drug-outlets-in-uganda
#20
JOURNAL ARTICLE
Moses Ocan, Loyce Nakalembe, Caroline Otike, Tayebwa Mordecai, Joan Birungi, Sam Nsobya
BACKGROUND: Malaria treatment in sub-Saharan Africa is faced with challenges including unreliable supply of efficacious agents, substandard medicines coupled with high price of artemisinin-based combinations. This affects access to effective treatment increasing risk of malaria parasite resistance development and adverse drug events. This study investigated access to quality-assured artemisinin-based combination therapy (QAACT) medicines among clients of selected private drug-outlets in Uganda...
April 30, 2024: Malaria Journal
keyword
keyword
73722
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.